Tetra Bio Pharma Inc TBPMQ

Healthcare Cannabis

Tetra Bio-Pharma Inc. is a Canada-based cannabinoid-derived drug discovery and development company. The Company has developed a pipeline of cannabinoid-based drug products for a range of medical conditions, including pain, inflammation, and oncology. The Company has a pipeline of formulations and drug delivery systems with a portfolio of assets from the early research and development phase to advanced stage clinical programs. Its products include QIXLEEF, CAUMZ, PPP004, REDUVO, and REBORN 1. QIXLEEF is a botanical therapy with a fixed dosage of tetrahydrocannabinol (THC) and cannabidiol (CBD). CAUMZ is its inhaled cannabinoid-derived drug candidate. PPP004 is a topical preparation containing either a standardized amount of CBD or a defined ratio of THC and CBD. REDUVO is a soft gel capsule used to treat chemotherapy-induced nausea and vomiting (CINV) and weight loss and severe nausea in people living with human immunodeficiency virus (HIV) infection. REBORN 1 is in phase II trial.

GREY:TBPMQ - Post by User

Tetra Bio Pharma Inc

<< Previous

Bullboard Posts

Next >>

Post by SamV21on Jan 12, 2022 10:28am

98 Views

Post# 34307845

Reality .115 , trademark worthless , Tetra not mentioned

Once again pure pumping and hype over nothing , trademark worth nothing without income , article link does not mention Tetra, no mention of either on Tetra website.Pumper noise , nothing from CEO or tetra since .Phase 1 means nothing , big blocks to stop it from falling further.TD now has a long buy at .06 cents., they did predict .12 cents months ago.Once again this guy thinks he knows more than the company does and pumps on nothing, linking articles he finds with no mention of tetra .

<< Previous

Bullboard Posts

Next >>

How a junior advances one of the largest undeveloped diamond projects